Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymosin-induced human serum factor increasing cyclic AMP.

A Astaldi, G C Astaldi, P Wijermans

    Journal of Immunology (Baltimore, Md. : 1950)
    |September 1, 1977
    PubMed
    Summary

    Thymosin does not directly alter thymocyte cyclic AMP. However, it triggers the appearance of a serum factor that elevates cyclic AMP in thymocytes, acting on a unique receptor.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hereditary elliptocytosis: Variable clinical severity caused by 3 variants in the α-spectrin gene.

    International journal of laboratory hematology·2018
    Same author

    Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study.

    Annals of hematology·2015
    Same author

    Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologists.

    The Netherlands journal of medicine·2014
    Same author

    A survey on diagnostic methods and treatment strategies used in patients with Waldenström's macroglobulinaemia in The Netherlands.

    The Netherlands journal of medicine·2013
    Same author

    Guidelines for the optimal use of muromonab CD3 in transplantation.

    BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
    Same author

    Epigenetic therapy with decitabine for myelodysplasia and leukemia.

    Future oncology (London, England)·2006

    Area of Science:

    • Immunology
    • Endocrinology
    • Cellular Biology

    Background:

    • Thymosin is a peptide hormone involved in immune system development.
    • The precise mechanism of thymosin's action on thymocytes is not fully understood.
    • Cyclic AMP (cAMP) is a crucial second messenger in cellular signaling.

    Purpose of the Study:

    • To investigate the in vitro effects of thymosin on thymocyte cyclic AMP (cAMP) levels.
    • To determine if thymosin interacts with beta-adrenergic or serum thymic factor (SF) receptors.
    • To characterize the nature of the factor induced by thymosin in patients with SF deficiency.

    Main Methods:

    • In vitro assays measuring cyclic AMP levels in thymocytes.
    • Receptor binding studies to assess thymosin interaction with beta-adrenergic and SF receptors.

    Related Experiment Videos

  • Analysis of serum factors from patients treated with thymosin.

    • Main Results:

    • Thymosin exhibited no direct in vitro effect on thymocyte cAMP levels.
    • Thymosin did not appear to bind to beta-adrenergic or SF receptors.
    • In thymosin-treated patients lacking SF activity, a novel serum factor emerged that increased thymocyte cAMP.
    • This induced factor acted on a membrane site distinct from beta-adrenergic receptors.

    Conclusions:

    • Thymosin's effect on thymocyte cAMP is indirect, mediated by an induced serum factor.
    • This induced factor represents a novel signaling pathway in thymocyte activation.
    • The findings suggest a complex regulatory role for thymosin in immune cell function.